SOFPRO – Software Protection Labs has released new update for their software copy protection and licensing solution for Windows, .NET Framework and .NET Core Windows applications.
[#] ACEN web licensing settings have been reorganized.
Main ACEN web licensing tab includes ACEN server settings, ACEN program ID and information about installed web licensing modules.
Settings tab include “If activation fails” and “If license is reset or expired” actions and settings which manage displaying of exceptions and standard errors.
Tasks tab include “License alive report” and “License validation” post activation tasks settings.
[*] ACEN Web licensing: “Check if license is removed” task is now “License validation” task.
Instead of only checking if license is removed from ACEN, license validation task will now also update local license in case license in ACEN is updated.
ACEN administrator users can change expiration dates for existing web licenses. License validation task will detect these changes and update originally issued license with new expiration date.
Note: This feature requires latest version of ACEN (05.00.20).
[+] ACEN Web licensing: “If license is changed” action added to license validation task.
Available actions:
“update license & show message” – protected application will update local license and show “License successfully updated.” message. This message (License_Updated) can be changed in language editor.
“update license” – protected application will update local license without showing notification message.
[+] ACEN Web licensing: “If activation fails” action and custom exit code options added.
Available “If activation fails” actions:
“show error and exit” – protected application will display error message and exit.
“exit” – protected application will just exit without showing any error message.
If custom exit code for activation failure is left to default value (0) protected application will return status code returned by ACEN. Otherwise, protected application will return custom exit code value.
[+] ACEN Web licensing: “If license is reset or expired” action and custom exit code options added to post activation settings.
Available “If license is reset or expired” actions:
“show error and exit” – protected application will display error message and exit.
“exit” – protected application will just exit without showing any error message.
“show error and reactivate license” – protected application will display error message and then automatically try to reactivate license.
“reactivate license” – protected application will automatically try to reactivate license.
[#] ACEN web licensing: license alive and license validation task are now enabled by default.
[#] Protection interface: RemoveLicense function will remove local license even if license removal feature was not enabled in project settings.
In case of application protected with ACEN web licensing enabled this function will remove local license only. ACEN web license will not be removed.
[!] Final step of protection wizard was not enabling view report and test buttons after successful protection process.
[>] Interface dll has been updated. Please be sure to update existing version with latest one.
About SOFPRO
SOFPRO – Software Protection Labs, https://www.sofpro.com is a well-known provider of professional software copy protection solutions for Windows, .NET framework and .NET Core Windows applications.
Software Protection Labs DOO
Pukovnika Purica 1
Belgrade 11000
Serbia, EU
https://www.sofpro.com
Let’s block ads! (Why?)
HOHHOT, CHINA - Media OutReach Newswire - 23 December 2024 - China's National Forestry and…
HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…
JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…
Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…
HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…
CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…